Category: Hong Kong Corporate News

Hong Kong Corporate News

Dah Sing Financial Holdings Announces HK$838.7 Million Acquisition of Viva Place Properties in Hong Kong – Discloseable Transaction Details

Minichart

March 2, 2026

DSFH Announces Major Property Acquisition in Hong Kong - Det...

Continue Reading 0

Hong Kong Corporate News

Hansoh Pharmaceutical’s Dalmelitinib Mesylate Tablets NDA Accepted by China’s NMPA for EGFR Mutation-Positive NSCLC Treatment 1

Minichart

March 2, 2026

Hansoh Pharmaceutical: New Drug Application Accepted by NMPA...

Continue Reading 0

Hong Kong Corporate News

Star Group Asia Limited Announces Major Property Disposal and Leaseback Arrangement in Causeway Bay, Hong Kong

Minichart

March 2, 2026

Star Group Asia Limited Announces Major Property Disposal an...

Continue Reading 0

Hong Kong Corporate News

Mokingran Jewellery Issues 2025 Profit Warning Despite Revenue Growth Due to Gold Contract Losses

Minichart

March 1, 2026

Mokingran Jewellery Issues Profit Warning for FY2025: Key De...

Continue Reading 0

Hong Kong Corporate News

Xinyi Glass Holdings Limited 2025 Annual Results: Revenue, Profit, Dividend, Business Review & Outlook

Minichart

March 1, 2026

Xinyi Glass Holdings Limited – 2025 Annual Results: Investor...

Continue Reading 0

Hong Kong Corporate News

E-House (China) Enterprise Holdings Limited Announces Update on Irrevocable Restructuring Support and Scheme Implementation Progress

Minichart

March 1, 2026

E-House (China) Enterprise Holdings Limited Provides Key Upd...

Continue Reading 0

Hong Kong Corporate News

Sinopec Kantons Announces Liquidation of Joint Venture Rizhao Shihua and RMB2.41 Billion Asset Disposal

Minichart

March 1, 2026

Sinopec Kantons Holdings - Liquidation of Joint Venture and ...

Continue Reading 0

Hong Kong Corporate News

Shanghai Henlius Biotech’s Pertuzumab Biosimilar HLX11 Receives Positive CHMP Opinion for EU Approval

Minichart

March 1, 2026

Key Highlights HLX11 (Pertuzumab Biosimilar) receives p...

Continue Reading 0

Hong Kong Corporate News

Shanghai Henlius Biotech Doses First Patient in Phase 2/3 Clinical Trial of HLX22 and HLX87 for HER2-Positive Breast Cancer in China 123

Minichart

March 1, 2026

Shanghai Henlius Biotech Doses First Patient in Pivotal Phas...

Continue Reading 0

Hong Kong Corporate News

Sino Harbour Holdings Chairman Increases Shareholding with 8.64 Million Shares Acquisition at HK$0.089 Each

Minichart

March 1, 2026

Sino Harbour Holdings Group - Chairman Increases Shareholdin...

Continue Reading 0

Category: Hong Kong Corporate News

Join Our Investing Seminar